Bioadhesive Ophthalmics
Orsay · Founded 2020
About Bioadhesive Ophthalmics
Bioadhesive Ophthalmics is a developer of a pharmaceutical platform that aims to transform ophthalmology by relieving patients from the burden of their eye diseases. The company's pharmaceutical technology includes a mucoadhesive ocular hydrogel insert that releases a therapeutic molecule medicinal substances to the eye continuously over a period of a week, thus enhancing the impact of treatment, enabling the eye patients to get ease from the complexity of frequent eye drop application by generating a continuous and controlled sustained hydrogel release. It was founded in Orsay, Ile-de-France, France by Jean Garrec and Jean Cuiné in 2020.
Company Facts
- Founded: 2020
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Mar 2020)
- Website: biophta.com
Social Profiles
Canonical: https://fsome.com/organization/bioadhesive-ophthalmics-8357987 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.